LOC100041430 can be inhibited by MAPK/ERK pathway inhibitors, such as PD98059 and U0126, work by blocking the activity of MEK, an upstream kinase, which in turn prevents the activation of ERK, a downstream effector that regulates various cellular responses. Similarly, PI3K/Akt pathway inhibitors, like LY294002, prevent the activation of Akt, a key signaling molecule involved in cell survival and growth. mTOR inhibitors, exemplified by Rapamycin, influence cellular growth and metabolism by acting on the mTOR complex, which is a central cell growth regulator.
Wnt/β-catenin pathway inhibitors, such as Wnt-C59 and XAV-939, interfere with the signaling cascade that leads to the accumulation of β-catenin in the nucleus, which affects gene transcription and cellular responses. AMPK pathway inhibitors, like Dorsomorphin, modulate energy balance within the cell by influencing AMPK, which is a sensor of cellular energy status. CDK4/6 inhibitors, such as Palbociclib, are known to halt the cell cycle by preventing the phosphorylation of retinoblastoma protein, thereby influencing cell division and proliferation.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
MAPK/ERK inhibitor. Blocks MEK, which is upstream of ERK, potentially decreasing LOC100041430 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
PI3K/Akt inhibitor. Prevents phosphorylation of Akt, possibly reducing LOC100041430 signaling. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
mTOR inhibitor. Could downregulate cellular processes influenced by LOC100041430 via mTOR pathway. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor. Modulates JNK signaling, potentially altering LOC100041430 activity if related. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
p38 MAPK inhibitor. Could attenuate p38-mediated signaling affecting LOC100041430 function. | ||||||
Wnt-C59 | 1243243-89-1 | sc-475634 sc-475634A sc-475634B | 5 mg 10 mg 50 mg | $210.00 $320.00 $1250.00 | 1 | |
Wnt/β-catenin pathway inhibitor. Possibly influences LOC100041430 by inhibiting Wnt signaling. | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $35.00 $115.00 $515.00 | 26 | |
Disrupts Wnt/β-catenin pathway. Could alter LOC100041430 function by inhibiting β-catenin. | ||||||
Dorsomorphin dihydrochloride | 1219168-18-9 | sc-361173 sc-361173A | 10 mg 50 mg | $182.00 $736.00 | 28 | |
AMPK inhibitor. May modulate LOC100041430's role by affecting AMPK signaling. | ||||||
IWP-2 | 686770-61-6 | sc-252928 sc-252928A | 5 mg 25 mg | $94.00 $286.00 | 27 | |
Inhibitor of Wnt production. May reduce LOC100041430 activity by limiting Wnt ligand availability. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $315.00 | ||
CDK4/6 inhibitor. By inhibiting CDK4/6, it could indirectly affect LOC100041430's role in cell cycle. | ||||||